Analysis of conformational determinants underlying HSP90-kinase interaction

about

Selective targeting of the stress chaperome as a therapeutic strategy Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.The Mysterious Ways of ErbB2/HER2 Trafficking

P2860

Q28248791-A5FAD924-623F-431D-A912-5DDD245ACC60 Q30374671-C4946A51-E6CA-4D1F-B27A-B8F86A6CB821 Q38237727-3D77F239-B005-4F43-876C-C93A8418EB64

P2860

Analysis of conformational determinants underlying HSP90-kinase interaction

Item

http://www.wikidata.org/entity/Q39127414

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Analysis of conformational determinants underlying HSP90-kinase interaction

@en

Analysis of conformational determinants underlying HSP90-kinase interaction.

@nl

type

Item

label

Analysis of conformational determinants underlying HSP90-kinase interaction

@en

Analysis of conformational determinants underlying HSP90-kinase interaction.

@nl

prefLabel

Analysis of conformational determinants underlying HSP90-kinase interaction

@en

Analysis of conformational determinants underlying HSP90-kinase interaction.

@nl

P1476

Analysis of conformational determinants underlying HSP90-kinase interaction

@en

P2093

Justus Duyster

http://www.w3.org/2001/XMLSchema#string

Natalie Bartosch

http://www.w3.org/2001/XMLSchema#string

Rama Krishna Kancha

http://www.w3.org/2001/XMLSchema#string

P2860

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein

Characterization of Ggrb4, an adapter protein interacting with Bcr-Abl

Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90

Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamy

Reversible resistance induced by FLT3 inhibition: a novel resistance mechanism in mutant FLT3-expressing cells

HSP90 at the hub of protein homeostasis: emerging mechanistic insights

HSP90 and the chaperoning of cancer

P304

e68394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0068394

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248398303

http://www.w3.org/2001/XMLSchema#string

P698

23844194

http://www.w3.org/2001/XMLSchema#string

P932

3699556

http://www.w3.org/2001/XMLSchema#string

Analysis of conformational determinants underlying HSP90-kinase interaction

about

P2860

P2860

Analysis of conformational determinants underlying HSP90-kinase interaction

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932